Saturday, 31 October 2026European Markets

JDE PEET'S And UNIBEL Have A High Dividend Yield And Return On Equity In The Packaged Foods Industry.

Loading stream...

(vianews) - jde peet's (jdep.as) is among this list of stock assets with the highest dividend rate and return on equity on the packaged foods industry.

financial asset price forward dividend yield return on equity
jde peet's (jdep.as) €18.71 3.81% 3.27%
unibel (unbl.pa) €965.00 1.12% 6.65%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. jde peet's (jdep.as)

3.81% forward dividend yield and 3.27% return on equity

jde peet's n.v., together with its subsidiaries, provides various coffee and tea products worldwide. it operates through larmea, apac, europe, and peet's segments. the company sells its products under the l'or, peet's, jacobs, senseo, tassimo, douwe egberts, oldtown, super, pickwick, and moccona brand names. it serves various businesses, such as offices, hotels, bars, and restaurants, as well as coffee stores. jde peet's n.v. was founded in 1753 and is headquartered in amsterdam, the netherlands. jde peet's n.v. operates as a subsidiary of acorn holdings b.v.

earnings per share

as for profitability, jde peet's has a trailing twelve months eps of €0.76.

pe ratio

jde peet's has a trailing twelve months price to earnings ratio of 24.62. meaning, the purchaser of the share is investing €24.62 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.27%.

volume

today's last reported volume for jde peet's is 20314 which is 91.26% below its average volume of 232685.

volatility

jde peet's's last week, last month's, and last quarter's current intraday variation average was a positive 0.44%, a negative 0.23%, and a positive 1.16%.

jde peet's's highest amplitude of average volatility was 1.58% (last week), 1.12% (last month), and 1.16% (last quarter).

more news about jde peet's.

2. unibel (unbl.pa)

1.12% forward dividend yield and 6.65% return on equity

unibel s.a. produces and sells cheese products in france. the company was incorporated in 1921 and is headquartered in paris, france.

earnings per share

as for profitability, unibel has a trailing twelve months eps of €43.04.

pe ratio

unibel has a trailing twelve months price to earnings ratio of 22.42. meaning, the purchaser of the share is investing €22.42 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.65%.

volume

today's last reported volume for unibel is 2 which is 50% below its average volume of 4.

more news about unibel.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com